News
November 23, 2010 – Study results found significant differences in men and women older than 80 who underwent carotid surgical incision and carotid artery angioplasty and stenting. The results were presented by Caron B. Rockman, M.D., associate professor of surgery at the New York University School of Medicine at the VEITHsymposium.
November 23, 2010
News
November 23, 2010 - A new technique that combines the heat and energy of ultrasound with the highly targeted delivery of clot-busting drugs appears to be effective at treating patients with acute massive pulmonary embolism (PE). The new treatment, called ultrasound-accelerated catheter-directed thrombolysis (CDT), was developed by the Ekos Corporation.
November 23, 2010Technology
Exam-Link is a regional health information organization (RHIO) image-sharing platform from CoActiv. The LINK provides ...
November 22, 2010Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
November 22, 2010 – At the VEITHsymposium, physicians debated whether stents are usually required in the endovenous treatment of chronic venous disease. Seshadri Raju M.D., professor emeritus of surgery at the University of Mississippi Medical Center in Flowood, Miss., said that detectable iliac vein stenosis is present in more than 90 percent of cases of chronic venous disease (CVD).
November 22, 2010News
November 22, 2010 – A new whole-body, integrated magnetic resonance imaging/positron emission tomography (MRI/PET) system is capable of simultaneous data acquisition.
November 22, 2010
News
November 22, 2010 - An implantable medical device used in the minimally invasive treatment of abdominal aortic aneurysms delivered strong results through one year of patient follow-up in a U.S. pivotal study. The trial data, which was presented at the VEITHsymposium, looked at the Endurant Stent Graft System, by Medtronic.
November 22, 2010Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
November 22, 2010 – Data presented at the American Heart Association’s Scientific Sessions 2010 showed that percutaneous renal nerve ablation reduces blood pressure. The data, which was also published in The Lancet was from the Symplicity HTN-2 trial and looked at Ardian’s Symplicity Catheter System.
November 22, 2010
Technology
November 22, 2010 – The first noninvasive cardiovascular monitor with blood pressure and cardiac output measurements has been cleared by the U.S. Food and Drug Administration (FDA). The ccNexfin, by BMEYE B.V., combines the company’s noninvasive technology with Masimo rainbow SET Pulse CO-Oximetry for continuous hemoglobin and oxygen saturation monitoring.
November 22, 2010
News
November 19, 2010 – A new cloud-based 3-D advanced visualization and decision support system was introduced at the VEITHsymposium. The Gore 3-D Imaging System is powered by TeraRecon intuition Cloud Technology, and lets physicians simply drag and drop image files to a secure server.
November 19, 2010Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
November 18, 2010 – After the initial findings from the CREST trial, debate continues to swirl as proponents of both carotid endarterectomy (CEA) and carotid angioplasty and stenting (CAS) claim superiority for their preferred intervention.
November 18, 2010News
November 18, 2010 – The Society of Cardiovascular Computed Tomography (SCCT) has collaborated with the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA) and other societies on the 2010 ACCF/AHA Guideline for assessing cardiovascular risk in asymptomatic adults. The guidelines were published at the American Heart Association’s Scientific Sessions.
November 18, 2010News
November 18, 2010 – In the trial of 1,623 patients with coronary heart disease (CHD) or CHD risk equivalents, an investigational CETP inhibitor showed no significant differences from placebo in the primary safety measures studied. Researchers this week presented results from the phase III DEFINE study with Merck's CETP inhibitor, anacetrapib.
November 18, 2010Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
November 17, 2010 – A lunch symposium detailing the evidence for simulation in medical training and other fields will be sponsored by W.L. Gore and Associates at the VEITHsymposium. The EVEResT (European Virtual Reality Endovascular Research Team) lunch symposium will take place Nov. 19 from 12:00 to 1:00 p.m. in the Gramercy A room, second floor.
November 17, 2010Technology
November 17, 2010 – Chronic heart failure patients treated with eplerenone (Inspra) experienced a significant reduction in risk of cardiovascular death or heart failure hospitalizations. The data comes from the EMPHASIS-HF trial, which compared Pfizer’s drug to placebo and standard therapy in patients with mild symptoms.
November 17, 2010
News
November 17, 2010 – Data from the ADVANCE bridge-to-heart-transplant study showed that 92 percent of patients were either alive on the implanted device, had a heart transplant or explanted for recovery. The study looked at the HeartWare Ventricular Assist System at 180 days.
November 17, 2010© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now